Quality of Life in Metastatic Breast Cancer (MBC) Patients in Second Line Monochemotherapy
NCT02403869 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 149
Last updated 2022-06-30
Summary
Post-authorization, prospective follow-up, multi-centre, national study to estimate definitive deterioration in the quality of life in patients with metastatic breast cancer treated with second-line monochemotherapy.
Conditions
- Breast Neoplasms
Sponsors & Collaborators
-
Celgene
lead INDUSTRY
Principal Investigators
-
Bristol-Myers Squibb · Bristol-Myers Squibb
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-03-12
- Primary Completion
- 2019-01-31
- Completion
- 2019-01-31
Countries
- Spain
Study Locations
More Related Trials
-
Prospective Construction and Validation of a Prognostic Score to Identify Among Patients With Metastatic Breast Cancer Those Who Benefit From a Third Line Chemotherapy in Terms of Overall Survival
NCT01574170 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Women With Locally Advanced Breast Cancer
NCT01998906 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective, Multicenter, Observational Cohort Study to Evaluate the Efficacy and Safety of a Novel Anti-tumor Drug As a Radiosensitizer in Patients with Advanced Breast Cancer Brain Metastasis.
NCT06839547 ·Status: NOT_YET_RECRUITING
-
Study of KN026 Monotherapy or Combination Therapy in Patients With Metastatic Breast Cancer
NCT04165993 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Intrathecal Trastuzumab Administration in Metastatic Breast Cancer Patients Developing Carcinomatous Meningitis
NCT01373710 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinico-biological Data Collection Study of Metastatic Breast Cancer
NCT03958136 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast Cancer
NCT00258960 ·Status: COMPLETED ·Phase: PHASE2
-
Capecitabine + Bendamustine in Women With Pretreated Locally Advanced or Metastatic Her2-negative Breast Cancer
NCT01891227 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Palbociclib With Exemestane Plus GnRH Versus Capecitabine in Premenopausal Women With HR+ MBC
NCT02592746 ·Status: UNKNOWN ·Phase: PHASE2
-
Analysis of Olaparib Response in Patients With BRCA1 and/or 2 Promoter Methylation Diagnosed of Advanced Breast Cancer
NCT03205761 ·Status: COMPLETED ·Phase: PHASE2
-
First Line Therapy for Patients With Metastatic Breast Cancer
NCT00456846 ·Status: TERMINATED ·Phase: PHASE2
-
To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
NCT03286842 ·Status: COMPLETED ·Phase: PHASE3
-
Survival Endpoints in Women Treated for Metastatic Breast Cancer: Contribution of Real-life Databases
NCT03676257 ·Status: COMPLETED
-
Dasatinib In Combination With Trastuzumab And Paclitaxel In First Line Treatment Of Her2-Positive MBC Patients
NCT01306942 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
GW572016 For Treatment Of Refractory Metastatic Breast Cancer
NCT00062686 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Two Regimens of Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer
NCT00005980 ·Status: COMPLETED ·Phase: PHASE2
-
Comparative Real World Tumor Response in Pre-menopausal Metastatic Breast Cancer Patients Treated With Palbociclib + Aromatase Inhibitor or Aromatase Inhibitor Alone
NCT05012644 ·Status: COMPLETED
-
Mono Efficacy of Capecitabine (MoniCa)
NCT00196820 ·Status: COMPLETED ·Phase: PHASE2
-
PalbocIclib in PreMenopausal Women With ER Positive/HER-2 Negative MetAstatic Breast Cancer
NCT02917005 ·Status: UNKNOWN ·Phase: PHASE2
-
Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer
NCT00036868 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating the Safety and Efficacy of Onartuzumab And/or Bevacizumab in Combination With Paclitaxel in Participants With Metastatic, Triple Negative Breast Cancer
NCT01186991 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Of Lapatinib With Carboplatin, Paclitaxel, and With or Without Trastuzumab In Metastatic Breast Cancer.
NCT00367471 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial in Patients With Breast Cancer Susceptibility Gene (BRCA) Defective Tumours
NCT01432145 ·Status: COMPLETED ·Phase: PHASE2
-
BP-C1 in Metastatic Breast Cancer Patients
NCT01861509 ·Status: COMPLETED ·Phase: PHASE1
-
The Impact of Adverse Events, Produced by Antibodies Conjugates, on Quality of Life in Patients With Metastatic Breast Cancer: Multicentric, Observational Study (EVA).
NCT06106711 ·Status: UNKNOWN